@article{98710c07ba724e4ea6be5cf6ed6f506b,
title = "Perspectives on the development of imatinib and the future of cancer research",
author = "Druker, {Brian J.}",
note = "Funding Information: I am indebted to my wife Alexandra and children, Holden, Julia and Claire for their love and support and the balance they provide to my life. I am extremely appreciative of the assistance from A. Hardy on the writing of this manuscript. This award was made possible by the hundreds of people who have assisted me in my career. This includes all of my current and former laboratory staff, my colleagues and mentors at Oregon Health & Science University, the clinical faculty, and our nurses and data managers. I would like to thank my mentors from the Dana-Farber Cancer Institute and the dedicated scientific and clinical staff at Novartis, who shepherded imatinib through clinical trials. I would also like to thank the numerous investigators who enrolled subjects on our clinical trials. During this time, I have been supported by various funding agencies, including the National Cancer Institute, the Leukemia and Lymphoma Society, the Burroughs Wellcome Fund, the T.J. Martell Foundation, the Doris Duke Charitable Foundation, and the American Cancer Society and the Howard Hughes Medical Institute. I am grateful for this support. Lastly, I would like to thank my patients who have gone on this incredible journey with me.",
year = "2009",
doi = "10.1038/nm1009-1149",
language = "English (US)",
volume = "15",
pages = "1149--1152",
journal = "Nature medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "10",
}